Which ECG abnormality is most likely in a 68-year-old man with COPD, obstructive sleep apnea, obesity, pulmonary hypertension, accentuated P2 and mild polycythemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ECG Findings in Pulmonary Hypertension with COPD

Right ventricular hypertrophy is the most likely ECG abnormality in this patient with documented pulmonary hypertension (mean PAP 35 mmHg), COPD, obesity, and accentuated P2. 1

Clinical Context Supporting RVH

This patient presents with classic features of pulmonary hypertension:

  • Confirmed hemodynamic diagnosis: Mean pulmonary artery pressure of 35 mmHg on cardiac catheterization establishes pulmonary hypertension (normal ≤20 mmHg) 1
  • Physical examination findings: Accentuated S2 (P2 component) is a cardinal sign of elevated pulmonary artery pressure 1
  • Secondary polycythemia: Elevated hematocrit/hemoglobin reflects chronic hypoxemia driving compensatory erythropoiesis 2
  • Multiple risk factors: COPD, obstructive sleep apnea, and obesity (BMI 32) all contribute to pulmonary hypertension development 2

Why RVH is Most Likely

ECG abnormalities correlate directly with pulmonary hypertension severity, and this patient has moderate pulmonary hypertension:

  • RVH occurs in 87% of patients with idiopathic pulmonary arterial hypertension 3
  • Right axis deviation is present in 79% of PAH patients 3
  • ECG sensitivity for RVH is 55% with 70% specificity when mean PAP is approximately 50 mmHg 1, 3
  • At mean PAP of 35 mmHg, ECG changes are common but not universal 1

The 2015 ESC/ERS guidelines explicitly state that ECG abnormalities are more likely in severe rather than mild PH, and this patient's mean PAP of 35 mmHg represents moderate disease where RVH is the expected finding 1

Specific ECG Patterns Expected

In COPD patients with pulmonary hypertension, look for:

  • Right axis deviation (most common, present in 79% of PAH) 3
  • Tall R waves in V1 with R/S ratio >1 3, 4
  • qR pattern in V1 (highly specific for RVH) 3, 5
  • Deep S waves in V5-V6 with R/S <1 3
  • RV strain pattern: ST depression and T-wave inversion in right precordial leads (V1-V3) 1, 3
  • P pulmonale: Tall P waves ≥2.5 mm in leads II, III, aVF indicating right atrial enlargement 3

Important caveat for COPD patients: The American College of Cardiology emphasizes that in COPD, RVH should only be diagnosed when R-wave amplitude in V1 is relatively increased, as other findings (low voltage, right axis deviation, persistent S waves) may reflect hyperinflation and geometric factors rather than true hypertrophy 3, 6

Why Other Options Are Less Likely

Absence of P waves (atrial fibrillation): While supraventricular arrhythmias occur in advanced pulmonary hypertension with cumulative incidence of 25% after 5 years, this patient has regular heart rate of 62/min, making atrial fibrillation unlikely 1

Left axis deviation: This finding suggests left ventricular pathology, not right-sided disease. The American College of Cardiology states that left axis deviation is more indicative of left ventricular hypertrophy rather than right-sided cardiac pathology 3. This patient's clinical picture points entirely to right heart involvement.

Premature ventricular contractions: The ESC/ERS guidelines note that ventricular arrhythmias are rare in pulmonary hypertension 1. While PACs and supraventricular tachyarrhythmias are more common in severe COPD (19% and 16% respectively), isolated PVCs are not a characteristic finding 6

ST segment elevation in V1-V3: This pattern suggests acute right ventricular infarction or anterior STEMI, neither of which fits this patient's chronic, progressive presentation over six months 1. The patient's symptoms are exertional and gradual, not acute coronary syndrome.

Diagnostic Accuracy Considerations

The diagnostic accuracy of ECG for RVH varies by underlying etiology:

  • Highest accuracy: Congenital heart disease 3
  • Intermediate accuracy: Acquired heart disease and primary pulmonary hypertension 3
  • Lowest accuracy: Chronic pulmonary disease (this patient's category) 3, 6

In severe COPD specifically, ECG findings include:

  • Right atrial enlargement in 44% (vs 15% in mild/moderate COPD) 6
  • RVH in 29% (vs 4% in mild/moderate COPD) 6
  • Right bundle branch block in 29% (vs 11% in mild/moderate COPD) 6
  • Low voltage in limb leads in 24% due to hyperinflation 6

Clinical Implications

The presence of RVH on ECG has prognostic significance:

  • P-wave amplitude in lead II ≥0.25 mV is associated with 2.8-fold increased risk of death over six years 3
  • Each 1 mm increase in P-wave amplitude in lead III confers 4.5-fold higher mortality risk 3
  • RVH with R/S >1 in V1 has 100% specificity and positive predictive value for distinguishing pulmonary arterial hypertension from pulmonary hypertension due to left ventricular diastolic dysfunction 4

Critical pitfall: Up to 13% of patients with severe PAH may have a completely normal ECG despite elevated pressures, so a normal ECG cannot rule out pulmonary hypertension 3. However, given this patient's moderate-to-severe disease with mean PAP of 35 mmHg and multiple clinical signs, ECG abnormalities are expected.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pulmonary hypertension in COPD.

The European respiratory journal, 2008

Guideline

Electrocardiographic Signs of Right Ventricular Overload

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Electrocardiographic abnormalities in patients with severe versus mild or moderate chronic obstructive pulmonary disease followed in an academic outpatient pulmonary clinic.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2011

Related Questions

What is the diagnosis for a baby with Right Ventricular Hypertrophy (RVH) and a Ventricular Septal Defect (VSD) with a pulmonary valve defect, likely due to a genetic deletion?
In a 68‑year‑old man with COPD, obstructive sleep apnea, obesity and pulmonary hypertension, which ECG finding is most likely: absent P waves, left axis deviation, premature ventricular contractions, right‑ventricular hypertrophy, or ST‑segment elevation in leads V1‑V3?
What is the best course of management for an elderly male patient with a history of Hypertension (HTN), Hyperlipidemia (HLD), Gastroesophageal Reflux Disease (GERD), and Chronic Obstructive Pulmonary Disease (COPD), presenting with increasing shortness of breath and periodic chest pressure, with normal stress test and echocardiogram results, and suspected Obstructive Sleep Apnea (OSA)?
What is the best medication for a patient with emphysema and hypertension?
In a 55‑year‑old woman with COPD on long‑acting β2‑agonist and inhaled corticosteroid who presents with worsening symptoms, ankle edema, decreased breath sounds, normal jugular venous pressure, stable vitals except an oxygen saturation of 86 % and an echocardiographic pulmonary artery pressure of 52 mm Hg, what is the most appropriate immediate management?
Is Seroquel (quetiapine) appropriate for treating insomnia, and what low dose and safety considerations should be used?
For an admitted patient with a TSH of 24 mIU/L, how often should thyroid function (free T4) be monitored during the hospital stay?
How should a 33-year-old woman with atypical squamous cells of undetermined significance (ASCUS) on Pap test and a negative high-risk human papillomavirus (HPV) test be managed?
Is it appropriate to administer vancomycin, azithromycin (Zithromax), and ceftriaxone (Rocephin) together for pneumonia?
In a 42‑year‑old man with schizophrenia on monthly Invega Sustenna (paliperidone palmitate) 78 mg and nightly clozapine 200 mg, with a neutrophil percentage of 76.8% and mean platelet volume of 10.8 fL, what hematologic monitoring and management are recommended?
Can clobetasol propionate gel be used intraorally?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.